Browse Guides  internal medicine  gastroenterology

Inflammatory bowel disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

There is no clear benefit from 
  • ciprofloxacin in Crohn's disease  d
  • metronidazole in ulcerative colitis d
  • vancomycin d
  • anti-tuberculous therapy for Crohn's disease a

Why?

  • Vancomycin does not clearly prevent surgery or subsquent relapses in active Crohn's disease or ulcerative colitis. d
  • Anti-TB therapy does not reduce stricture formation, surgery or steroid use in Crohn's disease. It also causes side-effects. a

Anti-tuberculosis therapy causes adverse effects

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNH
(95% CI)
Crohn's disease a anti-TB chemotherapy placebo adverse effects
at 2 years
4.8% -470%
(-1700% to -75%)
5
(3 to 10)
 

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   L   Friedman
CAT Writers   D   Ford , CM   Ball